Atom | NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Due Dates: January 5, 2026 (estimated)

Funding Amounts: Award size and duration vary by phase and agency; specific ceilings/floors not yet announced.

Summary: Supports U.S. small businesses in developing innovative health-related technologies through SBIR Phase I, II, Direct to Phase II, Fast-Track, and Phase IIB grants (clinical trials not allowed).

Key Information: This is a forecasted opportunity; final details depend on SBIR program reauthorization.

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Sign in to see full grant listing